JP2014133711A5 - - Google Patents

Download PDF

Info

Publication number
JP2014133711A5
JP2014133711A5 JP2013002066A JP2013002066A JP2014133711A5 JP 2014133711 A5 JP2014133711 A5 JP 2014133711A5 JP 2013002066 A JP2013002066 A JP 2013002066A JP 2013002066 A JP2013002066 A JP 2013002066A JP 2014133711 A5 JP2014133711 A5 JP 2014133711A5
Authority
JP
Japan
Prior art keywords
extract
scutellaria baicalensis
tea
lafuma
guava
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013002066A
Other languages
Japanese (ja)
Other versions
JP6204019B2 (en
JP2014133711A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2013002066A priority Critical patent/JP6204019B2/en
Priority claimed from JP2013002066A external-priority patent/JP6204019B2/en
Publication of JP2014133711A publication Critical patent/JP2014133711A/en
Publication of JP2014133711A5 publication Critical patent/JP2014133711A5/ja
Application granted granted Critical
Publication of JP6204019B2 publication Critical patent/JP6204019B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

グアバ（Psidium guajava）抽出物、プーアール茶（Puer tea）抽出物、ラフマ（Apocynum venetum）抽出物、ダイダイ（Citrus aurantium）抽出物、セイヨウネズ（Juniperus communis）抽出物、及びコガネバナ（Scutellaria baicalensis）抽出物からなる群より選ばれる少なくとも１種を有効成分とする、CGI-58発現促進剤。 Guava (Psidium guajava) extract, Pu-erh tea (Puer tea) extract, Lafuma (Apocynum venetum) extracts, da-by-die (Citrus aurantium) extract, juniper (Juniperus communis) extract, and Scutellaria baicalensis (Scutellaria baicalensis) extract A CGI-58 expression promoter comprising as an active ingredient at least one selected from the group consisting of: グアバ（Psidium guajava）抽出物、プーアール茶（Puer tea）抽出物、ラフマ（Apocynum venetum）抽出物、ダイダイ（Citrus aurantium）抽出物、セイヨウネズ（Juniperus communis）抽出物、及びコガネバナ（Scutellaria baicalensis）抽出物からなる群より選ばれる少なくとも１種を有効成分とする、皮膚機能改善剤。 Guava (Psidium guajava) extract, Pu-erh tea (Puer tea) extract, Lafuma (Apocynum venetum) extracts, da-by-die (Citrus aurantium) extract, juniper (Juniperus communis) extract, and Scutellaria baicalensis (Scutellaria baicalensis) extract A skin function improving agent comprising at least one selected from the group consisting of as active ingredients. グアバ（Psidium guajava）抽出物、プーアール茶（Puer tea）抽出物、ラフマ（Apocynum venetum）抽出物、ダイダイ（Citrus aurantium）抽出物、セイヨウネズ（Juniperus communis）抽出物、及びコガネバナ（Scutellaria baicalensis）抽出物からなる群より選ばれる少なくとも１種を有効成分とする、毛髪形成異常予防又は改善剤。 Guava (Psidium guajava) extract, Pu-erh tea (Puer tea) extract, Lafuma (Apocynum venetum) extracts, da-by-die (Citrus aurantium) extract, juniper (Juniperus communis) extract, and Scutellaria baicalensis (Scutellaria baicalensis) extract An agent for preventing or improving abnormal hair formation, comprising as an active ingredient at least one selected from the group consisting of:
JP2013002066A 2013-01-09 2013-01-09 CGI-58 expression promoter Active JP6204019B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013002066A JP6204019B2 (en) 2013-01-09 2013-01-09 CGI-58 expression promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013002066A JP6204019B2 (en) 2013-01-09 2013-01-09 CGI-58 expression promoter

Publications (3)

Publication Number Publication Date
JP2014133711A JP2014133711A (en) 2014-07-24
JP2014133711A5 true JP2014133711A5 (en) 2016-01-28
JP6204019B2 JP6204019B2 (en) 2017-09-27

Family

ID=51412283

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013002066A Active JP6204019B2 (en) 2013-01-09 2013-01-09 CGI-58 expression promoter

Country Status (1)

Country Link
JP (1) JP6204019B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7479038B2 (en) 2020-01-20 2024-05-08 日本メナード化粧品株式会社 Peptidylarginine deiminase 1 expression promoter

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092969A (en) * 1995-06-20 1997-01-07 O S Kogyo Kk Therapeutic agent for allergic disease
JP2001220312A (en) * 2000-02-09 2001-08-14 Ichimaru Pharcos Co Ltd Cosmetic composition containing steam distillate of plant
JP2007001914A (en) * 2005-06-23 2007-01-11 Nippon Menaade Keshohin Kk Skin barrier function-improving agent
JP2008105985A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Hyaluronic acid production promoter, skin care preparation for external use, bathing agent, and food and drink
JP2009256270A (en) * 2008-04-18 2009-11-05 Maruzen Pharmaceut Co Ltd Insulin-like growth factor-1 expression promoting agent

Similar Documents

Publication Publication Date Title
EP3687527A4 (en) Compositions comprising cannabidiol, tetrahydrocannabinol, terpenes, and flavonoids and use thereof in the treatment of insomnia
WO2015042449A3 (en) Novel streptococcus vaccines
CA2865972C (en) Inhalable dry powders
PL2941263T3 (en) A purified extract isolated from pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
SG10201804817TA (en) Delayed release compositions of linaclotide
WO2014197816A8 (en) Stimulus responsive nanocomplexes and methods of use thereof
CA2915027A1 (en) Compositions and methods for administration of vaccines against dengue virus
WO2011043631A3 (en) Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound
WO2015095735A3 (en) Vaccine compositions and uses thereof
HK1245631A1 (en) Hydroalcoholic extract of schinus molle, cosmetic compositions comprising the same and cosmetic uses thereof
WO2016085127A3 (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same
BR112016012489A2 (en) capsule, method of preparing a capsule containing total desmodium styracifolium flavonoids, and use of the capsule
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
WO2015173701A3 (en) Pharmaceutical compositions comprising danirixin for treating infectious diseases
EP3521409A3 (en) Perfume systems
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
WO2014102483A3 (en) Cosmetic or dermatological composition made of iris extracts and use thereof
WO2011141708A3 (en) New particles of tetracyclines and protecting agent
MY190399A (en) A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject
JP2014133711A5 (en)
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
WO2015195835A3 (en) Improved alpha-v beta-8 antibodies
WO2015037019A3 (en) Modified release pharmaceutical formulations